Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders

Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Haemophilia : the official journal of the World Federation of Hemophilia 2023-03, Vol.29 (2), p.676-680
Hauptverfasser: Saey, Stephanie, Sharathkumar, Anjali, Watkinson, Karla, Krantz, Michelle, Currie, Allison, Perepu, Usha, Shinkle, Marie
Format: Artikel
Sprache:eng
Schlagworte:
Blood Platelet Disorders
Deamino Arginine Vasopressin - therapeutic use
Desmopressin
Hemostatics
Humans
von Willebrand Diseases - drug therapy
von Willebrand Factor - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 680
container_issue 2
container_start_page 676
container_title Haemophilia : the official journal of the World Federation of Hemophilia
container_volume 29
creator Saey, Stephanie
Sharathkumar, Anjali
Watkinson, Karla
Krantz, Michelle
Currie, Allison
Perepu, Usha
Shinkle, Marie
description
doi_str_mv 10.1111/hae.14744
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2766721856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2766721856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3134-9893e6e5f9c3b126ffbfa2c9384f9937351fd429f9dd265341fdfd6ef8fa18ce3</originalsourceid><addsrcrecordid>eNp10ctOHSEYB3DS2NRLu-gLGBI3uhgdLsMZ3Bk9rU1O0o3W5YSBjxwMZxiB8fIovq2cju2iSQkJl_z4B_gQ-krqU1La2VrBKeELzj-gPcJEU9GGiJ3tvCFVS4nYRfsp3dc1YbQWn9AuE4JLLtgeel1BzhBxDjivAS-NyyGe4-XzCNHBoAE_ubzGaer1lNUAYUrYQNqEMUJKbsCljyoXmtNMH8OA75z30Ec1GGxcApUAH_-6uzrB252HSXmXy5lHwKNXGTxkbKdBZ1eOFh-igZg-o49W-QRf3scDdPtteXN5Xa1-fv9xebGqNCOMV7KVDAQ0VmrWEyqs7a2iWrKWWynZonyBNZxKK42homG8LK0RYFurSKuBHaDjOXeM4WGClLuNSxq8n1_b0YUQC0raRhR69A-9D1Mcyu2KaoWsayZYUSez0jGkFMF2Y3QbFV86UnfbenWlXt3vehV7-J449Rswf-WfAhVwNoMn5-Hl_0nd9cVyjnwD-_Oh2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786900363</pqid></control><display><type>article</type><title>Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Saey, Stephanie ; Sharathkumar, Anjali ; Watkinson, Karla ; Krantz, Michelle ; Currie, Allison ; Perepu, Usha ; Shinkle, Marie</creator><creatorcontrib>Saey, Stephanie ; Sharathkumar, Anjali ; Watkinson, Karla ; Krantz, Michelle ; Currie, Allison ; Perepu, Usha ; Shinkle, Marie</creatorcontrib><identifier>ISSN: 1351-8216</identifier><identifier>EISSN: 1365-2516</identifier><identifier>DOI: 10.1111/hae.14744</identifier><identifier>PMID: 36649463</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Blood Platelet Disorders ; Deamino Arginine Vasopressin - therapeutic use ; Desmopressin ; Hemostatics ; Humans ; von Willebrand Diseases - drug therapy ; von Willebrand Factor - therapeutic use</subject><ispartof>Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.676-680</ispartof><rights>2023 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3134-9893e6e5f9c3b126ffbfa2c9384f9937351fd429f9dd265341fdfd6ef8fa18ce3</cites><orcidid>0000-0001-7084-686X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhae.14744$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhae.14744$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36649463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saey, Stephanie</creatorcontrib><creatorcontrib>Sharathkumar, Anjali</creatorcontrib><creatorcontrib>Watkinson, Karla</creatorcontrib><creatorcontrib>Krantz, Michelle</creatorcontrib><creatorcontrib>Currie, Allison</creatorcontrib><creatorcontrib>Perepu, Usha</creatorcontrib><creatorcontrib>Shinkle, Marie</creatorcontrib><title>Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders</title><title>Haemophilia : the official journal of the World Federation of Hemophilia</title><addtitle>Haemophilia</addtitle><subject>Blood Platelet Disorders</subject><subject>Deamino Arginine Vasopressin - therapeutic use</subject><subject>Desmopressin</subject><subject>Hemostatics</subject><subject>Humans</subject><subject>von Willebrand Diseases - drug therapy</subject><subject>von Willebrand Factor - therapeutic use</subject><issn>1351-8216</issn><issn>1365-2516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10ctOHSEYB3DS2NRLu-gLGBI3uhgdLsMZ3Bk9rU1O0o3W5YSBjxwMZxiB8fIovq2cju2iSQkJl_z4B_gQ-krqU1La2VrBKeELzj-gPcJEU9GGiJ3tvCFVS4nYRfsp3dc1YbQWn9AuE4JLLtgeel1BzhBxDjivAS-NyyGe4-XzCNHBoAE_ubzGaer1lNUAYUrYQNqEMUJKbsCljyoXmtNMH8OA75z30Ec1GGxcApUAH_-6uzrB252HSXmXy5lHwKNXGTxkbKdBZ1eOFh-igZg-o49W-QRf3scDdPtteXN5Xa1-fv9xebGqNCOMV7KVDAQ0VmrWEyqs7a2iWrKWWynZonyBNZxKK42homG8LK0RYFurSKuBHaDjOXeM4WGClLuNSxq8n1_b0YUQC0raRhR69A-9D1Mcyu2KaoWsayZYUSez0jGkFMF2Y3QbFV86UnfbenWlXt3vehV7-J449Rswf-WfAhVwNoMn5-Hl_0nd9cVyjnwD-_Oh2w</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Saey, Stephanie</creator><creator>Sharathkumar, Anjali</creator><creator>Watkinson, Karla</creator><creator>Krantz, Michelle</creator><creator>Currie, Allison</creator><creator>Perepu, Usha</creator><creator>Shinkle, Marie</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7084-686X</orcidid></search><sort><creationdate>202303</creationdate><title>Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders</title><author>Saey, Stephanie ; Sharathkumar, Anjali ; Watkinson, Karla ; Krantz, Michelle ; Currie, Allison ; Perepu, Usha ; Shinkle, Marie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3134-9893e6e5f9c3b126ffbfa2c9384f9937351fd429f9dd265341fdfd6ef8fa18ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Blood Platelet Disorders</topic><topic>Deamino Arginine Vasopressin - therapeutic use</topic><topic>Desmopressin</topic><topic>Hemostatics</topic><topic>Humans</topic><topic>von Willebrand Diseases - drug therapy</topic><topic>von Willebrand Factor - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saey, Stephanie</creatorcontrib><creatorcontrib>Sharathkumar, Anjali</creatorcontrib><creatorcontrib>Watkinson, Karla</creatorcontrib><creatorcontrib>Krantz, Michelle</creatorcontrib><creatorcontrib>Currie, Allison</creatorcontrib><creatorcontrib>Perepu, Usha</creatorcontrib><creatorcontrib>Shinkle, Marie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saey, Stephanie</au><au>Sharathkumar, Anjali</au><au>Watkinson, Karla</au><au>Krantz, Michelle</au><au>Currie, Allison</au><au>Perepu, Usha</au><au>Shinkle, Marie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders</atitle><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle><addtitle>Haemophilia</addtitle><date>2023-03</date><risdate>2023</risdate><volume>29</volume><issue>2</issue><spage>676</spage><epage>680</epage><pages>676-680</pages><issn>1351-8216</issn><eissn>1365-2516</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36649463</pmid><doi>10.1111/hae.14744</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7084-686X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1351-8216
ispartof Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.676-680
issn 1351-8216
1365-2516
language eng
recordid cdi_proquest_miscellaneous_2766721856
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Blood Platelet Disorders
Deamino Arginine Vasopressin - therapeutic use
Desmopressin
Hemostatics
Humans
von Willebrand Diseases - drug therapy
von Willebrand Factor - therapeutic use
title Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A31%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20to%20the%20Editor:%20Experience%20with%20subcutaneous%20desmopressin%20in%20patients%20with%20von%20Willebrand%20disease%20(VWD)%20and%20qualitative%20platelet%20function%20disorders&rft.jtitle=Haemophilia%20:%20the%20official%20journal%20of%20the%20World%20Federation%20of%20Hemophilia&rft.au=Saey,%20Stephanie&rft.date=2023-03&rft.volume=29&rft.issue=2&rft.spage=676&rft.epage=680&rft.pages=676-680&rft.issn=1351-8216&rft.eissn=1365-2516&rft_id=info:doi/10.1111/hae.14744&rft_dat=%3Cproquest_cross%3E2766721856%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2786900363&rft_id=info:pmid/36649463&rfr_iscdi=true